Medicare part D prescribing for direct oral anticoagulants in the United States: Cost, use and the "rubber effect".
IntroductionDirect oral anticoagulants (DOAC) have gained an increased share over warfarin for prevention and treatment of thromboembolic disease.We studied DOAC adoption across providers and medical specialties.MethodsRetrospective, cross-sectional analysis of Medicare Part D public use files (PUF), 2013 to 2015.We summarized prescription data for